CUC INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,658 JPY | -3.60% |
|
-4.44% | -25.75% |
| 04-25 | Japanese Shares Lead Asia Sell-Off as Tech Stocks Weigh; CUC Sumps 19% Despite Upbeat Earnings | MT |
| 04-25 | CUC's Attributable Net Income Jumps 7% in Fiscal Year Ended March; Stock Slumps 14% | MT |
| Sales 2024 | 33.02B 211M 16.58B | Sales 2025 * | 43.13B 275M 21.66B | Capitalization | 50.42B 322M 25.32B |
|---|---|---|---|---|---|
| Net income 2024 | 2.6B 16.57M 1.3B | Net income 2025 * | 2.36B 15.09M 1.19B | EV / Sales 2024 | 2.71 x |
| Net Debt 2024 | 10.18B 65M 5.11B | Net Debt 2025 * | 14.51B 92.66M 7.29B | EV / Sales 2025 * | 1.51 x |
| P/E ratio 2024 |
28.8
x | P/E ratio 2025 * |
21.3
x | Employees | 3,159 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 23.6% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.60% | ||
| 1 week | -4.44% | ||
| Current month | -2.41% | ||
| 1 month | -30.16% | ||
| 3 months | -39.84% | ||
| 6 months | -37.69% | ||
| Current year | -25.75% |
1 week
1 625.00
1 868.00
1 month
1 494.002 430.00
Current year
1 494.003 055.00
1 year
1 494.005 130.00
3 years
1 494.005 130.00
5 years
1 494.005 130.00
10 years
1 494.005 130.00
| Managers | Title | Age | Since |
|---|---|---|---|
Keita Hamaguchi
FOU | Founder | 50 | 07/08/14 |
Matsuura Toshio
HRO | Human Resources Officer | - | - |
Hashimoto Jun
PRN | Corporate Officer/Principal | - | 31/12/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ryoichi Yonemura
BRD | Director/Board Member | 64 | 31/05/20 |
Keiji Ohba
BRD | Director/Board Member | 43 | 31/05/20 |
Keita Hamaguchi
FOU | Founder | 50 | 07/08/14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/05/24 | 1,658 | -3.60% | 97 400 |
| 21/05/24 | 1,720 | -6.22% | 115,800 |
| 20/05/24 | 1,834 | +1.83% | 152,000 |
| 17/05/24 | 1,801 | -2.65% | 207,400 |
| 16/05/24 | 1,850 | +6.63% | 166,900 |
Delayed Quote Japan Exchange, May 22, 2024 at 07:00 am
More quotes
CUC Inc is a Japan-based company primarily engaged in the medical institution support business and the home health care nursing business. The Company operates its business through two segments. The Medical Institution Support segment provides various operational support to medical institutions, mainly in the areas of management strategy support, business management support, and personnel and labor management support. The Home Health Care Nursing segment provides home health care nursing services, including the operation of home health care nursing stations and home hospices. The Company is also engaged in dispensing pharmacy services and sales services of ophthalmic materials and eyeglass supplies.
Calendar
23/07/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1,720
JPY
Average target price
2,700
JPY
Spread / Average Target
+56.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -25.75% | 323M | |
| +18.63% | 84.11B | |
| +2.04% | 27.25B | |
| -9.66% | 17.31B | |
| -1.82% | 16.83B | |
| +3.96% | 15.92B | |
| +7.75% | 13.68B | |
| +72.83% | 13.29B | |
| +72.50% | 12.73B | |
| +2.71% | 12.62B |
- Stock Market
- Equities
- 9158 Stock
